1-18 of 18
Harold E Lebovitz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Meeting Abstracts

Dosing Time of Insulin Tregopil, a Novel Oral Insulin, in Type 2 Diabetes Mellitus Patients and Its Pharmacodynamic Effect

ANAND P. KHEDKAR, VINU JOSE, HAROLD E. LEBOVITZ, ALAN D. CHERRINGTON, GILBERT ALEXANDER FLEMING, SANDEEP N. ATHALYE, ASHWINI VISHWESWARAMURTHY
Journal: Diabetes
Diabetes 2018;67(Supplement_1):979-P
https://doi.org/10.2337/db18-979-P
Published: 01 July 2018
View article titled, Dosing Time of Insulin Tregopil, a Novel Oral Insulin, in Type 2 Diabetes Mellitus Patients and Its Pharmacodynamic Effect
Meeting Abstracts

Pharmacodynamic Effect of Novel Oral Insulin Tregopil in Relation to Meal Composition in Type 2 Diabetes Mellitus Patients

ANAND P. KHEDKAR, VINU JOSE, HAROLD E. LEBOVITZ, ALAN D. CHERRINGTON, GILBERT ALEXANDER FLEMING, SANDEEP N. ATHALYE, ASHWINI VISHWESWARAMURTHY
Journal: Diabetes
Diabetes 2018;67(Supplement_1):346-OR
https://doi.org/10.2337/db18-346-OR
Published: 01 July 2018
View article titled, Pharmacodynamic Effect of Novel Oral Insulin Tregopil in Relation to Meal Composition in Type 2 Diabetes Mellitus Patients
Journal Articles

Long-Term Normoglycemic Remission in Black Newly Diagnosed NIDDM Subjects

Mary Ann Banerji, Rochelle L Chaiken, Harold E Lebovitz
Journal: Diabetes
Diabetes 1996;45(3):337–341
https://doi.org/10.2337/diab.45.3.337
Published: 01 March 1996
View article titled, Long-Term Normoglycemic Remission in Black Newly Diagnosed NIDDM Subjects
Open the PDF for Long-Term Normoglycemic Remission in Black Newly Diagnosed NIDDM Subjects in another window
Journal Articles

Prolongation of Near-Normoglycemic Remission in Black NIDDM Subjects With Chronic Low-Dose Sulfonylurea Treatment

Mary Ann Banerji, Rochelle L Chaiken, Harold E Lebovitz
Journal: Diabetes
Diabetes 1995;44(4):466–470
https://doi.org/10.2337/diab.44.4.466
Published: 01 April 1995
View article titled, Prolongation of Near-Normoglycemic Remission in Black NIDDM Subjects With Chronic Low-Dose Sulfonylurea Treatment
Open the PDF for Prolongation of Near-Normoglycemic Remission in Black NIDDM Subjects With Chronic Low-Dose Sulfonylurea Treatment in another window
Journal Articles

Does Intra-Abdominal Adipose Tissue in Black Men Determine Whether NIDDM Is Insulin-Resistant or Insulin-Sensitive?

Mary Ann Banerji, Rochelle L Chaiken, David Gordon, John G Kral, Harold E Lebovitz
Journal: Diabetes
Diabetes 1995;44(2):141–146
https://doi.org/10.2337/diab.44.2.141
Published: 01 February 1995
View article titled, Does Intra-Abdominal Adipose Tissue in Black Men Determine Whether NIDDM Is Insulin-Resistant or Insulin-Sensitive?
Open the PDF for Does Intra-Abdominal Adipose Tissue in Black Men Determine Whether NIDDM Is Insulin-Resistant or Insulin-Sensitive? in another window
Journal Articles

GAD Antibody Negative NIDDM in Adult Black Subjects with Diabetic Ketoacidosis and Increased Frequency of Human Leukocyte Antigen DR3 and DR4: Flatbush Diabetes

Mary Ann Banerji, Rochelle L Chaiken, Howard Huey, Tiinamaija Tuomi, Allen J Norin, Ian R Mackay, Merrill J Rowley, Paul Z Zimmet, Harold E Lebovitz
Journal: Diabetes
Diabetes 1994;43(6):741–745
https://doi.org/10.2337/diab.43.6.741
Published: 01 June 1994
View article titled, GAD Antibody Negative NIDDM in Adult Black Subjects with Diabetic Ketoacidosis and Increased Frequency of Human Leukocyte Antigen DR3 and DR4: Flatbush Diabetes
Open the PDF for GAD Antibody Negative NIDDM in Adult Black Subjects with Diabetic Ketoacidosis and Increased Frequency of Human Leukocyte Antigen DR3 and DR4: Flatbush Diabetes in another window
Journal Articles

Do Blacks With NIDDM Have an Insulin-Resistance Syndrome?

Rochelle L Chaiken, Mary Ann Banerji, Howard Huey, Harold E Lebovitz
Journal: Diabetes
Diabetes 1993;42(3):444–449
https://doi.org/10.2337/diab.42.3.444
Published: 01 March 1993
View article titled, Do Blacks With NIDDM Have an Insulin-Resistance Syndrome?
Open the PDF for Do Blacks With NIDDM Have an Insulin-Resistance Syndrome? in another window
Journal Articles

Insulin-Sensitive and Insulin-Resistant Variants in NIDDM

Mary Ann Banerji, Harold E Lebovitz
Journal: Diabetes
Diabetes 1989;38(6):784–792
https://doi.org/10.2337/diab.38.6.784
Published: 01 June 1989
View article titled, Insulin-Sensitive and Insulin-Resistant Variants in NIDDM
Open the PDF for Insulin-Sensitive and Insulin-Resistant Variants in NIDDM in another window
Journal Articles

Glucose Intolerance in the Carcinoid Syndrome

Jerome M Feldman, MD, James W Plonk, MD, Carl H Bivens, MD, Harold E Lebovitz, MD
Journal: Diabetes
Diabetes 1975;24(7):664–671
https://doi.org/10.2337/diab.24.7.664
Published: 01 July 1975
View article titled, Glucose Intolerance in the Carcinoid Syndrome
Open the PDF for Glucose Intolerance in the Carcinoid Syndrome in another window
Journal Articles

Potentiation of Tolbutamide-mediated Insulin Release in Adult Onset Diabetics by Methysergide Maleate

John A Baldridge, M.D., Kenneth E Quickel, Jr, M.D., Jerome M Feldman, M.D., Harold E Lebovitz, M.D.
Journal: Diabetes
Diabetes 1974;23(1):21–24
https://doi.org/10.2337/diab.23.1.21
Published: 01 January 1974
View article titled, Potentiation of Tolbutamide-mediated Insulin Release in Adult Onset Diabetics by Methysergide Maleate
Open the PDF for Potentiation of Tolbutamide-mediated Insulin Release in Adult Onset Diabetics by Methysergide Maleate in another window
Journal Articles

Potentiation of Insulin Secretion in Vitro by Serotonin Antagonists

Jerome M Feldman, M.D., Kenneth E Quickel, Jr, M.D., Harold E Lebovitz, M.D.
Journal: Diabetes
Diabetes 1972;21(7):779–788
https://doi.org/10.2337/diab.21.7.779
Published: 01 July 1972
View article titled, Potentiation of Insulin Secretion in Vitro by Serotonin Antagonists
Open the PDF for Potentiation of Insulin Secretion in Vitro by Serotonin Antagonists in another window
Journal Articles

Endocrine and Metabolic Effects of Glybenclamide: Evidence for an Extrapancreatic Mechanism of Action

Jerome M Feldman, M.D., Harold E Lebovitz, M.D., L Lebovitz, R.N.
Journal: Diabetes
Diabetes 1971;20(11):745–755
https://doi.org/10.2337/diab.20.11.745
Published: 01 November 1971
View article titled, Endocrine and Metabolic Effects of Glybenclamide: Evidence for an Extrapancreatic Mechanism of Action
Open the PDF for Endocrine and Metabolic Effects of Glybenclamide: Evidence for an Extrapancreatic Mechanism of Action in another window
Journal Articles

Specificity of Serotonin Inhibition of Insulin Release from Golden Hamster Pancreas

Jerome M Feldman, M.D., Harold E Lebovitz, M.D.
Journal: Diabetes
Diabetes 1970;19(7):475–479
https://doi.org/10.2337/diab.19.7.475
Published: 01 July 1970
View article titled, Specificity of Serotonin Inhibition of Insulin Release from Golden Hamster Pancreas
Open the PDF for Specificity of Serotonin Inhibition of Insulin Release from Golden Hamster Pancreas in another window
Journal Articles

Mechanism of Epinephrine and Serotonin Inhibition of Insulin Release in the Golden Hamster in Vitro

Jerome M Feldman, M.D., Harold E Lebovitz, M.D.
Journal: Diabetes
Diabetes 1970;19(7):480–486
https://doi.org/10.2337/diab.19.7.480
Published: 01 July 1970
View article titled, Mechanism of Epinephrine and Serotonin Inhibition of Insulin Release in the Golden Hamster in Vitro
Open the PDF for Mechanism of Epinephrine and Serotonin Inhibition of Insulin Release in the Golden Hamster in Vitro in another window
Journal Articles

Inhibition of Glucose Oxidase Paper Tests by Reducing Metabolites

Jerome M Feldman, M.D., William N Kelley, M.D., Harold E Lebovitz, M.D
Journal: Diabetes
Diabetes 1970;19(5):337–343
https://doi.org/10.2337/diab.19.5.337
Published: 01 May 1970
View article titled, Inhibition of Glucose Oxidase Paper Tests by Reducing Metabolites
Open the PDF for Inhibition of Glucose Oxidase Paper Tests by Reducing Metabolites in another window
Journal Articles

Biological Activities of Tolbutamide and Its Metabolites: A Dissociation of Insulin-releasing and Hypoglycemic Activity

Jerome M Feldman, M.D., Harold E Lebovitz, M.D.
Journal: Diabetes
Diabetes 1969;18(8):529–537
https://doi.org/10.2337/diab.18.8.529
Published: 01 August 1969
View article titled, Biological Activities of Tolbutamide and Its Metabolites: A Dissociation of Insulin-releasing and Hypoglycemic Activity
Open the PDF for Biological Activities of Tolbutamide and Its Metabolites: A Dissociation of Insulin-releasing and Hypoglycemic Activity in another window
Journal Articles

An Insulin Dependent Effect of Chronic Tolbutamide Administration on the Skeletal Muscle Carbohydrate Transport System

Jerome M Feldman, M.D., Harold E Lebovitz, M.D.
Journal: Diabetes
Diabetes 1969;18(2):84–95
https://doi.org/10.2337/diab.18.2.84
Published: 01 February 1969
View article titled, An Insulin Dependent Effect of Chronic Tolbutamide Administration on the Skeletal Muscle Carbohydrate Transport System
Open the PDF for An Insulin Dependent Effect of Chronic Tolbutamide Administration on the Skeletal Muscle Carbohydrate Transport System in another window
Journal Articles

Tranylcypromine: A Potent Insulin Secretagogue and Hypoglycemic Agent

Rubin Bressler, M.D., Mario Vargas-Cordon, M.D., Harold E Lebovitz, M.D.
Journal: Diabetes
Diabetes 1968;17(10):617–624
https://doi.org/10.2337/diab.17.10.617
Published: 01 October 1968
View article titled, Tranylcypromine: A Potent Insulin Secretagogue and Hypoglycemic Agent
Open the PDF for Tranylcypromine: A Potent Insulin Secretagogue and Hypoglycemic Agent in another window